{
  "ticker": "EW",
  "year": 2023,
  "quarter": 2,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 141,
  "transactions": [
    {
      "id": 88349,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181683,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-06-30",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 88394,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 88417,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 131871,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131896,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 181738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-06-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181767,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-06-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 88423,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 131902,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 181774,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-06-13",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "40055.7795"
    },
    {
      "id": 88329,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 131794,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 181657,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-06-01",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "115559.8200"
    },
    {
      "id": 88437,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 131918,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 181790,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-24",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 88449,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 131933,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 181808,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-17",
      "transaction_shares": "8496.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "19248.0000"
    },
    {
      "id": 88328,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 88339,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 88340,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 88360,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 88378,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 88398,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 88445,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 88451,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 131793,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 131804,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 131806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 131830,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 131851,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 131875,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 131928,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 131935,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 181656,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LAVIOLETTE PAUL A",
      "reporting_owner_cik": "0001191249",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7718.0000"
    },
    {
      "id": 181667,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "VALERIANI NICHOLAS J",
      "reporting_owner_cik": "0001263149",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "68914.0000"
    },
    {
      "id": 181669,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Marsh Martha H.",
      "reporting_owner_cik": "0001500281",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "31880.0000"
    },
    {
      "id": 181695,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Sequeira Ramona",
      "reporting_owner_cik": "0001811081",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "5103.0000"
    },
    {
      "id": 181716,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "4485.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "86209.8200"
    },
    {
      "id": 181744,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "LORANGER STEVEN R",
      "reporting_owner_cik": "0001226924",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "55420.0000"
    },
    {
      "id": 181801,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "GALLAHUE KIERAN",
      "reporting_owner_cik": "0001308428",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "2803.0000"
    },
    {
      "id": 181810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-05-12",
      "transaction_shares": "2803.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "30283.0000"
    },
    {
      "id": 88347,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 88377,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 88385,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 88399,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 88407,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 88420,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 88429,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 88462,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 131816,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 131850,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 131860,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 131876,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 131884,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 131899,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 131908,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 131947,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 181680,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-11",
      "transaction_shares": "22525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "44552.8735"
    },
    {
      "id": 181715,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6475.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "25450.0000"
    },
    {
      "id": 181725,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6525.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "35055.7795"
    },
    {
      "id": 181745,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1575.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "173664.7785"
    },
    {
      "id": 181754,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-11",
      "transaction_shares": "9450.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "27744.0000"
    },
    {
      "id": 181771,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-05-11",
      "transaction_shares": "7775.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "213793.7137"
    },
    {
      "id": 181780,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-11",
      "transaction_shares": "1800.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "13035.7904"
    },
    {
      "id": 181822,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-11",
      "transaction_shares": "6425.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "39502.6931"
    },
    {
      "id": 88331,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 88335,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 131796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 131800,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 181659,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-10",
      "transaction_shares": "2500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "35577.6931"
    },
    {
      "id": 181663,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-10",
      "transaction_shares": "80700.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "98994.0000"
    },
    {
      "id": 88338,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 88343,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 88354,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 88356,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 88358,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 88362,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 88381,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 88461,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 131803,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 131809,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 131824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 131826,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 131828,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 131832,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 131854,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 131946,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 181666,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3413.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "21764.0000"
    },
    {
      "id": 181673,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-05-07",
      "transaction_shares": "20777.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "81724.8200"
    },
    {
      "id": 181688,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5003.0000",
      "transaction_price": "0.0000",
      "transaction_type": "M",
      "shares_after_transaction": "25783.8735"
    },
    {
      "id": 181690,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-07",
      "transaction_shares": "134.0000",
      "transaction_price": "88.7400",
      "transaction_type": "F",
      "shares_after_transaction": "11396.7904"
    },
    {
      "id": 181692,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-07",
      "transaction_shares": "4708.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "32060.7795"
    },
    {
      "id": 181697,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-07",
      "transaction_shares": "5415.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "210365.7137"
    },
    {
      "id": 181719,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-07",
      "transaction_shares": "3355.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "172417.7785"
    },
    {
      "id": 181821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-07",
      "transaction_shares": "6062.0000",
      "transaction_price": "0",
      "transaction_type": "M",
      "shares_after_transaction": "22972.0000"
    },
    {
      "id": 88346,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 131814,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 181678,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-05",
      "transaction_shares": "5635.0000",
      "transaction_price": "88.6250",
      "transaction_type": "S",
      "shares_after_transaction": "56224.6931"
    },
    {
      "id": 88337,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 88345,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 88357,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 88366,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 88391,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 88416,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 88425,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 88432,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 131802,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 131813,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 131827,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 131836,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 131867,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 131895,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 131904,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 131912,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 181665,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "President",
      "transaction_date": "2023-05-03",
      "transaction_shares": "359.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "21150.8735"
    },
    {
      "id": 181677,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-05-03",
      "transaction_shares": "103.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "11646.7904"
    },
    {
      "id": 181691,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-05-03",
      "transaction_shares": "433.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "17351.0000"
    },
    {
      "id": 181701,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "CVP & Grp President TAVR & SSH",
      "transaction_date": "2023-05-03",
      "transaction_shares": "383.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "205346.7137"
    },
    {
      "id": 181733,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-05-03",
      "transaction_shares": "37.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "169100.7785"
    },
    {
      "id": 181766,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-05-03",
      "transaction_shares": "468.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "62355.6931"
    },
    {
      "id": 181776,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-05-03",
      "transaction_shares": "281.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "18630.0000"
    },
    {
      "id": 181784,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-05-03",
      "transaction_shares": "327.0000",
      "transaction_price": "87.8100",
      "transaction_type": "F",
      "shares_after_transaction": "27696.7795"
    },
    {
      "id": 88330,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 131795,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 181658,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "SELLERS ROBERT W.A.",
      "reporting_owner_cik": "0001600739",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2023-04-28",
      "transaction_shares": "12270.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "24019.7904"
    },
    {
      "id": 52583,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 88434,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 131914,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 181786,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": "Chairman & CEO",
      "transaction_date": "2023-04-14",
      "transaction_shares": "29375.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "90322.8200"
    },
    {
      "id": 52526,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 52547,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 88351,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 88382,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 131821,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 131855,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    },
    {
      "id": 181685,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6640.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "175777.7785"
    },
    {
      "id": 181720,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-04-06",
      "transaction_shares": "6725.0000",
      "transaction_price": "35.1967",
      "transaction_type": "M",
      "shares_after_transaction": "69548.6931"
    }
  ]
}